Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-03-06 Purchase |
2025-03-06 5:53 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
10,000 | $5.015 | $50,150 | 2,295,731 (Direct) |
View |
| 2025-03-05 Purchase |
2025-03-05 5:19 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
10,000 | $5.02 | $50,200 | 2,285,731 (Direct) |
View |
| 2025-03-03 Purchase |
2025-03-04 4:45 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
10,000 | $4.705 | $47,050 | 2,275,731 (Direct) |
View |
| 2025-02-28 Purchase |
2025-02-28 5:30 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
10,000 | $4.76 | $47,600 | 2,361,730 (Direct) |
View |
| 2025-02-27 Purchase |
2025-02-27 4:13 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
10,000 | $4.76 | $47,600 | 2,351,730 (Direct) |
View |
| 2025-02-26 Purchase |
2025-02-26 4:46 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
10,000 | $4.765 | $47,650 | 2,341,730 (Direct) |
View |
| 2025-02-25 Purchase |
2025-02-25 7:38 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
10,000 | $4.464 | $44,640 | 2,331,730 (Direct) |
View |
| 2025-02-21 Purchase |
2025-02-24 7:04 pm |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
2,000 | $4.3894 | $8,779 | 356,398 (Indirect Direct) |
View |
| 2024-11-14 Sale |
2024-11-18 5:45 pm |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
5,000 | $5.1726 | $25,863 | 44,857 (Direct) |
View |
| 2024-07-29 Sale |
2024-07-29 5:24 pm |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
2,251 | $5.9203 | $13,327 | 229,398 (Indirect Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 4:50 pm |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
17,088 | $4.2903 | $73,313 | 196,825 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 4:48 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
16,727 | $4.2997 | $71,921 | 129,789 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 4:47 pm |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
55,172 | $4.193 | $231,339 | 1,871,730 (Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 4:46 pm |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
14,700 | $4.3124 | $63,393 | 231,649 (Indirect Direct) |
View |
| 2024-03-04 Sale |
2024-03-06 4:46 pm |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
17,411 | $4.2145 | $73,379 | 313,569 (Direct) |
View |
| 2023-08-21 Sale |
2023-08-23 4:23 pm |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
3,724 | $5.84 | $21,748 | 113,816 (Direct) |
View |
| 2023-08-10 Sale |
2023-08-11 4:36 pm |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
6,500 | $6.0537 | $39,349 | 29,328 (Direct) |
View |
| 2023-07-28 Sale |
2023-08-01 4:30 pm |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
2,212 | $6.3041 | $13,945 | 121,349 (Indirect Direct) |
View |
| 2023-06-15 Sale |
2023-06-20 4:34 pm |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
16,000 | $6.2944 | $100,710 | 123,561 (Indirect Direct) |
View |
| 2023-06-13 Sale |
2023-06-15 4:20 pm |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
14,600 | $6.5585 | $95,754 | 88,913 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-01 Tax Withholding |
2025-03-04 4:46 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
15,520 | $4.76 | 239,269 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 4:46 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
26,941 | $4.76 | 411,628 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 4:45 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
95,999 | $4.76 | 2,275,731 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 4:45 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
26,941 | $4.76 | 329,457 (Direct) |
View |
| 2025-03-01 Tax Withholding |
2025-03-04 4:44 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
26,941 | $4.76 | 294,884 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 8:21 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
125,000 | $0 | 254,789 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 7:45 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
450,000 | $0 | 2,321,730 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 7:44 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
125,000 | $0 | 354,398 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 7:44 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
125,000 | $0 | 438,569 (Direct) |
View |
| 2025-02-18 Option Award |
2025-02-20 7:43 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
125,000 | $0 | 321,825 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 4:43 pm |
N/A 2034-05-21 |
Vanda Pharmaceuticals Inc. | VNDA | Chrousos Phaedra Director |
62,089 | $0 | 104,327 (Direct) |
View |
| 2024-05-17 Option Award |
2024-05-21 4:55 pm |
N/A 2034-05-16 |
Vanda Pharmaceuticals Inc. | VNDA | Honore Tage Director |
58,107 | $0 | 101,822 (Direct) |
View |
| 2024-05-17 Option Award |
2024-05-21 4:53 pm |
N/A 2034-05-16 |
Vanda Pharmaceuticals Inc. | VNDA | DUGAN RICHARD W Director |
58,107 | $0 | 155,807 (Direct) |
View |
| 2024-05-17 Option Award |
2024-05-21 4:53 pm |
N/A 2034-05-16 |
Vanda Pharmaceuticals Inc. | VNDA | Mitchell Stephen Ray Director |
58,107 | $0 | 87,435 (Direct) |
View |
| 2024-05-17 Option Award |
2024-05-21 4:52 pm |
N/A 2034-05-16 |
Vanda Pharmaceuticals Inc. | VNDA | Ward Anne Sempowski Director |
58,107 | $0 | 97,420 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 4:53 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Williams Timothy SVP & General Counsel |
125,000 | $0 | 213,913 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 4:52 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Wijkstrom Joakim SVP, Chief Marketing Officer |
32,700 | $0 | 146,516 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 4:52 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Moran Kevin Patrick SVP, CFO & Treasurer |
125,000 | $0 | 246,349 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 4:52 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Polymeropoulos Mihael Hristos President and CEO |
450,000 | $0 | 1,926,902 (Direct) |
View |
| 2024-02-16 Option Award |
2024-02-21 4:50 pm |
N/A N/A |
Vanda Pharmaceuticals Inc. | VNDA | Birznieks Gunther SVP, Business Development |
125,000 | $0 | 330,980 (Direct) |
View |
| 2023-06-08 Option Award |
2023-06-12 4:20 pm |
N/A 2033-06-07 |
Vanda Pharmaceuticals Inc. | VNDA | Ward Anne Sempowski Director |
51,267 | $0 | 73,273 (Direct) |
View |